1Cell.Ai Named Best Healthtech Startup 2026

Recognised for Innovation in Precision Oncology & Patient Impact

x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    FAQ’s

    NGS for Oncologists

    Clinical guidance, indications, technology and lab capabilities for Next-Generation Sequencing in oncology practice.

    All
    Clinicians
    Patients
    Cost, TAT & Logistics
    CTC Testing
    Interpreting Reports
    Liquid Biopsy & ctDNA
    NGS for Oncologists
    Tissue NGS
    Back to FAQ's
    01 When should NGS testing be ordered in cancer patients? Clinicians

    NGS testing is ideally ordered at diagnosis of advanced or metastatic disease, before starting systemic therapy, so results can guide first-line treatment selection. It’s also valuable at disease progression or when resistance develops, to identify new actionable alterations and inform the next line of therapy.

    No results found!

    Still have questions?

    Need help understanding your report?

    Our oncology support team can help clinicians and patients navigate precision oncology insights — from sample logistics to interpreting actionable variants.

    NABL & CAP accredited lab · Pune, India · 1800 123 12355

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.